S&P 500   5,096.27 (+0.52%)
DOW   38,996.39 (+0.12%)
QQQ   439.00 (+0.86%)
AAPL   180.75 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.13 (+1.26%)
GOOGL   138.46 (+1.53%)
AMZN   176.76 (+2.08%)
TSLA   201.88 (-0.08%)
NVDA   791.12 (+1.87%)
NIO   5.75 (+5.89%)
AMD   192.53 (+9.06%)
BABA   74.03 (-0.75%)
T   16.93 (-0.18%)
F   12.44 (+1.14%)
MU   90.61 (+1.00%)
CGC   3.29 (-2.08%)
GE   156.89 (+0.82%)
DIS   111.58 (+0.70%)
AMC   4.32 (-13.43%)
PFE   26.56 (-1.78%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)
S&P 500   5,096.27 (+0.52%)
DOW   38,996.39 (+0.12%)
QQQ   439.00 (+0.86%)
AAPL   180.75 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.13 (+1.26%)
GOOGL   138.46 (+1.53%)
AMZN   176.76 (+2.08%)
TSLA   201.88 (-0.08%)
NVDA   791.12 (+1.87%)
NIO   5.75 (+5.89%)
AMD   192.53 (+9.06%)
BABA   74.03 (-0.75%)
T   16.93 (-0.18%)
F   12.44 (+1.14%)
MU   90.61 (+1.00%)
CGC   3.29 (-2.08%)
GE   156.89 (+0.82%)
DIS   111.58 (+0.70%)
AMC   4.32 (-13.43%)
PFE   26.56 (-1.78%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)
S&P 500   5,096.27 (+0.52%)
DOW   38,996.39 (+0.12%)
QQQ   439.00 (+0.86%)
AAPL   180.75 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.13 (+1.26%)
GOOGL   138.46 (+1.53%)
AMZN   176.76 (+2.08%)
TSLA   201.88 (-0.08%)
NVDA   791.12 (+1.87%)
NIO   5.75 (+5.89%)
AMD   192.53 (+9.06%)
BABA   74.03 (-0.75%)
T   16.93 (-0.18%)
F   12.44 (+1.14%)
MU   90.61 (+1.00%)
CGC   3.29 (-2.08%)
GE   156.89 (+0.82%)
DIS   111.58 (+0.70%)
AMC   4.32 (-13.43%)
PFE   26.56 (-1.78%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)
S&P 500   5,096.27 (+0.52%)
DOW   38,996.39 (+0.12%)
QQQ   439.00 (+0.86%)
AAPL   180.75 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.13 (+1.26%)
GOOGL   138.46 (+1.53%)
AMZN   176.76 (+2.08%)
TSLA   201.88 (-0.08%)
NVDA   791.12 (+1.87%)
NIO   5.75 (+5.89%)
AMD   192.53 (+9.06%)
BABA   74.03 (-0.75%)
T   16.93 (-0.18%)
F   12.44 (+1.14%)
MU   90.61 (+1.00%)
CGC   3.29 (-2.08%)
GE   156.89 (+0.82%)
DIS   111.58 (+0.70%)
AMC   4.32 (-13.43%)
PFE   26.56 (-1.78%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)

Adverum Biotechnologies (ADVM) SEC Filings & 10K Form

$1.98
+0.01 (+0.51%)
(As of 04:00 PM ET)

Recent Adverum Biotechnologies SEC Filings

DateFilerForm TypeView
02/22/2024
2:47 PM
Adverum Biotechnologies (Subject)
Adverum Biotechnologies (Subject)
Logos Global Management LP (Filed by)
Logos Global Management LP (Filed by)
Form SC 13G
02/21/2024
2:39 PM
Adverum Biotechnologies (Filer)
Form D
Notice of Exempt Offering of Securities 
02/15/2024
3:17 PM
Adverum Biotechnologies (Subject)
TCG Crossover GP II, LLC (Filed by)
Form SC 13G
02/14/2024
7:26 PM
Adverum Biotechnologies (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Form SC 13G/A
02/13/2024
6:34 PM
Adverum Biotechnologies (Subject)
BANK OF AMERICA CORP /DE/ (Filed by)
Form SC 13G/A
02/12/2024
9:13 AM
Adverum Biotechnologies (Subject)
MORGAN STANLEY (Filed by)
Form SC 13G/A
02/09/2024
4:50 PM
Adverum Biotechnologies (Issuer)
Lupher, Jr. Mark L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
4:51 PM
Adverum Biotechnologies (Issuer)
Scopa James Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
7:35 AM
Adverum Biotechnologies (Subject)
FMR LLC (Filed by)
Form SC 13G/A
02/08/2024
7:45 AM
Adverum Biotechnologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/07/2024
10:36 AM
Adverum Biotechnologies (Subject)
BML Investment Partners, L.P. (Filed by)
Form SC 13G/A
02/06/2024
3:47 PM
Adverum Biotechnologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2023
6:54 PM
Adverum Biotechnologies (Issuer)
Nicholson, C. David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2023
6:52 PM
Adverum Biotechnologies (Issuer)
Nicholson, C. David (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/06/2023
3:10 PM
Adverum Biotechnologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/18/2023
5:54 PM
Adverum Biotechnologies (Issuer)
Seyedkazemi Setareh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2023
3:14 PM
Adverum Biotechnologies (Issuer)
Rubinstein Linda M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2023
3:16 PM
Adverum Biotechnologies (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Form SC 13G
06/13/2023
5:19 PM
Adverum Biotechnologies (Issuer)
Ozden Rabia Gurses (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2023
4:17 PM
Adverum Biotechnologies (Issuer)
Scopa James Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2023
4:02 PM
Adverum Biotechnologies (Issuer)
Machado Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2023
4:03 PM
Adverum Biotechnologies (Issuer)
Hong Soo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2023
4:05 PM
Adverum Biotechnologies (Issuer)
Lupher, Jr. Mark L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2023
4:10 PM
Adverum Biotechnologies (Issuer)
Svoronos Dawn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2023
4:13 PM
Adverum Biotechnologies (Issuer)
Tuckson Reed Vaughn (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2023
4:15 PM
Adverum Biotechnologies (Issuer)
Whitcup Scott M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/25/2023
5:29 AM
Adverum Biotechnologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2023
11:15 PM
Adverum Biotechnologies (Filer)
Form EFFECT
04/25/2023
4:21 PM
Adverum Biotechnologies (Filer)
Form S-3
Registration statement under Securities Act of 1933  
04/14/2023
5:03 AM
Adverum Biotechnologies (Filer)
Form PRE 14A
03/30/2023
3:51 PM
Adverum Biotechnologies (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/17/2023
5:01 PM
Adverum Biotechnologies (Issuer)
Fischer Laurent (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2023
5:02 PM
Adverum Biotechnologies (Issuer)
Soparkar Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2023
5:02 PM
Adverum Biotechnologies (Issuer)
Riley Brigit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2023
4:21 PM
Adverum Biotechnologies (Issuer)
Fischer Laurent (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2023
4:22 PM
Adverum Biotechnologies (Issuer)
Soparkar Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2023
4:23 PM
Adverum Biotechnologies (Issuer)
Beckman Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2023
4:24 PM
Adverum Biotechnologies (Issuer)
Seyedkazemi Setareh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2023
4:24 PM
Adverum Biotechnologies (Issuer)
Riley Brigit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:ADVM) was last updated on 2/29/2024 by MarketBeat.com Staff